0 The best of 2018 – an A–Z of infectious diseases research
Want to discover the best research that’s occurred this year? Editor, Martha Powell, highlights the best of 2018’s infectious diseases research in an A–Z.
Browsing: Disease Area > Parasitic
0 WHO World Malaria Report 2018: launch of country-led response to put control efforts back on track
With progress plateauing for a second consecutive year and global financing also levelling off, the WHO has called for a ‘high burden to high impact’ country-led strategy.
0 Could malaria be detected by sniffer dogs?
New research suggests dogs could be trained to detect malaria in people, potentially allowing early detection and prevention of spread.
0 Recent advances and an update on gastrointestinal infections
Gauri Godbole, from Public Health England, gives us an overview of recent advances and updates in the field of gastrointestinal infections – from the impact of the microbiome to the growing threat of antimicrobial resistance.
0 CRISPR–Cas9 gene drive used to collapse malaria-carrying mosquito populations
Researchers from Imperial College London have reported their recent success in using ‘gene drive’ technology to block female mosquito reproduction, resulting in the total collapse of caged populations of Anopheles gambiae in as little as 7–11 generations.
0 Drug candidates identified for the prevention of malarial parasite maturation
A team of researchers from Imperial College London (UK) have identified compounds which prevent the malarial parasite sexually maturing inside the mosquito.
0 Genomics in malaria – an interview with Dyann Wirth
Genomics is increasingly being adopted into both research and clinical settings. Here, we speak to Dyann Wirth about the use of genomics in the field of malaria, from what it can uncover about the parasite to the hurdles that need to be overcome moving towards elimination.
0 Visceral leishmaniasis reported to be on the rise in Brazil
Researchers have reported that, despite control efforts, the incidence of visceral leishmaniasis has risen between 1990 and 2016.
0 From TB to leprosy: financial model reveals where pipelines and investments might fall short
Financial modelling has been used to estimate the costs and likelihood of candidate medicines, vaccines, diagnostics and technologies launching, revealing gaps in the pipeline and in funding.
0 7-year trial discovers ocular chlamydia infection rebounds after azithromycin cessation
Continuous mass distribution of azithromycin in northern Ethiopia is effective for trachoma prevention but doesn’t eliminate the disease entirely, according to new research.
